Imagion Biosystems Ltd
(ASX:IBX)
Our Latest Articles on Imagion Biosystems Ltd
| Type | Date | Title |
|---|---|---|
| Article | 14-Aug-2019 | One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market |
Market Data
Latest Article
One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market
Aug 14, 2019
MagSense is a unique, non-invasive, patent protected technology that fits into myriad addressable cancer diagnostic markets collectively worth $166 billion dollars and growing at 7% annually.
